Literature DB >> 8079968

Risk factors for infection and immunoglobulin replacement therapy in adult nephrotic syndrome.

M Ogi1, H Yokoyama, N Tomosugi, Y Hisada, S Ohta, M Takaeda, T Wada, T Naito, K Ikeda, S Goshima.   

Abstract

Infection has been recognized as an important cause of morbidity and mortality in children with nephrotic syndrome. However, the incidence and severity of infection and the mechanisms responsible for the increased susceptibility to infection are still unclear in adults. We studied 86 consecutive adult patients with nephrotic syndrome but no diabetic nephropathy. Risk factors for infection were evaluated by logistic regression analysis. Infections were found in 16 patients (19%), of whom six died of infection and two developed end-stage renal failure associated with infection. The relative risk for bacterial infection among patients with serum immunoglobulin G (IgG) levels below 600 mg/dL was 6.74 compared with that for patients with serum IgG levels over 600 mg/dL (95% confidence interval, 1.22 to 36.32; P = 0.029). In patients with serum creatinine levels over 2.0 mg/dL, the relative risk of bacterial infection was 5.31 compared with patients with serum creatinine levels below 2.0 mg/dL (95% confidence interval, 1.08 to 26.09; P = 0.040). Intravenous immunoglobulin (10 to 15 g) was administered prospectively every 4 weeks to 18 patients with serum IgG levels below 600 mg/dL until serum IgG levels increased to over 600 mg/dL. Administration of immunoglobulin resulted in a decreased rate of bacterial infections to a level equal to that in patients with endogenous levels over 600 mg/dL. These data indicate that hypogammaglobulinemia and renal insufficiency are independent risk factors for bacterial infection in adult patients with nephrotic syndrome. The effects of intravenous immunoglobulin suggest that maintenance of serum IgG levels over 600 mg/dL may reduce the risk of infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8079968     DOI: 10.1016/s0272-6386(12)80899-7

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  17 in total

Review 1.  Nephrotic syndrome in adults.

Authors:  Richard P Hull; David J A Goldsmith
Journal:  BMJ       Date:  2008-05-24

2.  Relapse and its remission in Japanese patients with idiopathic membranous nephropathy.

Authors:  Shinji Kitajima; Kengo Furuichi; Norihiko Sakai; Akihiro Sagara; Yasuyuki Shinozaki; Tadashi Toyama; Yasunori Iwata; Miho Shimizu; Hitoshi Yokoyama; Shuichi Kaneko; Takashi Wada
Journal:  Clin Exp Nephrol       Date:  2014-06-24       Impact factor: 2.801

3.  Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).

Authors:  Hitoshi Yokoyama; Hitoshi Sugiyama; Ichiei Narita; Takao Saito; Kunihiro Yamagata; Saori Nishio; Shouichi Fujimoto; Noriko Mori; Yukio Yuzawa; Seiya Okuda; Shoichi Maruyama; Hiroshi Sato; Yoshihiko Ueda; Hirofumi Makino; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2014-09-18       Impact factor: 2.801

Review 4.  Interventions for preventing infection in nephrotic syndrome.

Authors:  Hong Mei Wu; Jin-Ling Tang; Li Cao; Zhao Hui Sha; Youping Li
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18

5.  Nephrotic Syndrome Complications - New and Old. Part 2.

Authors:  Ruxandra Mihaela Busuioc; Gabriel Mircescu
Journal:  Maedica (Bucur)       Date:  2022-06

Review 6.  Membranous nephropathy in the older adult: epidemiology, diagnosis and management.

Authors:  Jeroen K J Deegens; Jack F M Wetzels
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

Review 7.  The nephrotic syndrome: pathogenesis and treatment of edema formation and secondary complications.

Authors:  Melissa A Cadnapaphornchai; Oleksandra Tkachenko; Dmitry Shchekochikhin; Robert W Schrier
Journal:  Pediatr Nephrol       Date:  2013-08-30       Impact factor: 3.714

8.  Differential effects of cyclophosphamide and mycophenolate mofetil on cellular and serological parameters in patients with systemic lupus erythematosus.

Authors:  Till Fassbinder; Ute Saunders; Eva Mickholz; Elisabeth Jung; Heidemarie Becker; Bernhard Schlüter; Annett Marita Jacobi
Journal:  Arthritis Res Ther       Date:  2015-04-03       Impact factor: 5.156

9.  Infectious Complications in Patients with Primary Glomerulonephritis over 10 Years: A Single-Center Experience in Turkey.

Authors:  Rezzan Eren Sadioglu; Sahin Eyupoglu; Siyar Erdogmus; Gizem Kumru Sahin; Fugen Yoruk; Sim Kutlay; Kenan Keven; Sehsuvar Erturk; Sule Sengul
Journal:  Kidney Dis (Basel)       Date:  2020-09-09

10.  Infection-Related Acute Care Events among Patients with Glomerular Disease.

Authors:  Dorey A Glenn; Candace D Henderson; Michelle O'Shaughnessy; Yichun Hu; Andrew Bomback; Keisha Gibson; Larry A Greenbaum; Jarcy Zee; Laura Mariani; Ronald Falk; Susan Hogan; Amy Mottl
Journal:  Clin J Am Soc Nephrol       Date:  2020-10-20       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.